74 results
8-K
EX-10.1
SMTI
Sanara MedTech Inc
18 Apr 24
Sanara MedTech Inc. Announces $55 Million Debt Facility
9:20am
Subsidiary in any Asset Sale and (ii) upon the reversal (without the satisfaction of any applicable liabilities in cash in a corresponding amount) of any … Interests solely because they may be (i) delivered to Borrower or any Subsidiary (or withheld by Borrower or such Subsidiary) in satisfaction of any
8-K
SMTI
Sanara MedTech Inc
18 Apr 24
Sanara MedTech Inc. Announces $55 Million Debt Facility
9:20am
or a multiple of $5.0 million and occur between the Closing Date and June 30, 2025, subject to the satisfaction of certain conditions, including
8-K
EX-10.1
SMTI
Sanara MedTech Inc
5 Apr 24
Departure of Directors or Certain Officers
9:15am
of the covenants and restrictions, which have been explained to Employee’s satisfaction. Employee hereby agrees that the limitations set forth above are reasonable … 7 and will not run in favor of Employee until such time that Employee cures the violation to the reasonable satisfaction of Employer. If Employee
8-K
EX-2.1
qc1h9
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-10.2
g8n8fcip9t1w
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
DEFA14A
phgku95px ytp
28 Apr 23
Additional proxy soliciting materials
4:01pm
8-K
EX-99.1
hupdnp k7
14 Nov 22
Sanara MedTech Inc. Announces Third Quarter 2022 Results
4:40pm
8-K
EX-2.1
ynvzbf x9yvq1rxpfwj
5 Jul 22
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
9:20am
8-K
EX-10.1
y7ty0n5fzznq9mnq b7f
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-10.2
b9ldgp3pp4ro2s1
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-10.3
7oux99x3zetlp12mkosv
8 Apr 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
n7vt oehxrup
8 Apr 22
Entry into a Material Definitive Agreement
4:15pm